Generate a tailored SOP for Dr. Kevin Struhl. Improve your application with a focused, well-structured draft.
Kevin Struhl is a leading researcher in the fields of biological chemistry and molecular pharmacology. His research focuses on the mechanistic relationships between chromatin structure and transcriptional regulation, particularly in the context of epigenetic inheritance and heterochromatin. Struhl employs a variety of approaches, including genetic, molecular, biochemical, and genomic techniques, to elucidate the transcriptional regulatory circuits involved in cellular transformation and the formation of cancer stem cells. His current projects explore the roles of co-activators, chromatin-modifying complexes, and regulatory elements in transcriptional control mechanisms. He is also investigating the impact of environmental signals on transcription and the molecular pathways required for the differentiation of cancer stem cells. Struhl's innovative research includes identifying mRNA stability factors and developing personalized therapies for cancer treatment utilizing existing drugs like metformin. He has a strong commitment to advancing the understanding of transcriptional regulation and its implications for cancer biology.
Harvard University • Boston, MA
Leading the research group focused on transcriptional regulation and chromatin structure.
Administered by the Harvard Kenneth C. Griffin Graduate School of Arts and Sciences (GSAS).